/Trending News: North America Organic Wine Market Overview And Forecast Report 2020-2026 – Top Players: Applied Satellite Technology Ltd, CLS Fisheries, Orolia Maritime, Remora Costa Rica and Visma
Trending News: North America Organic Wine Market Overview And Forecast Report 2020-2026 – Top Players: Applied Satellite Technology Ltd, CLS Fisheries, Orolia Maritime, Remora Costa Rica and Visma
organic wine market in North America is expected to grow from US$ 1630.33 million in 2019 to US$ 3895.59 million by 2027; it is estimated to grow at a CAGR of 11.6% from 2020 to 2027.
tipFebruary 8, 2021 40
organic wine market in North America is expected to grow from US$ 1630.33 million in 2019 to US$ 3895.59 million by 2027; it is estimated to grow at a CAGR of 11.6% from 2020 to 2027. Organic wine is made without using prohibited substances or genetic engineering. It undergoes the same rigorous requirements of USDA organic certification as other products throughout i
MedCity News
Bristol Myers lymphoma therapy acquired in Celgene deal wins FDA nod
After some setbacks and delays, the FDA approved Bristol Myers Squibb’s Breyanzi for certain lymphomas. It’s the fourth CAR T treatment to win the regulatory nod and the first under a new regenerative medicine designation.
Shares1
A Bristol Myers Squibb cancer immunotherapy that the pharmaceutical giant obtained via its Celgene acquisition was awarded FDA approval Friday, adding one more of this type of personalized medicine as a treatment option for certain forms of lymphoma.
The FDA approved the therapy, lisocabtagene maraleucel, as a treatment for adults who have certain types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL), whose cancer has not responded to or has relapsed after at least two other types of treatment. New York-based BMS will market the drug under the name Breyanzi.
5 February 2021
NEW YORK and LONDON - February 5, 2021 (GLOBE NEWSWIRE) - Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) ( Tiziana or the Company ), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces the appointment of Dr Thomas Adams, Ph.D. as an executive director. Dr Adams will assume the position of Head of Drug Development with immediate effect and his executive role will be to manage and oversee all matters relating to the Company s pre-clinical and clinical drug development programs and associated intellectual property. Dr Thomas H Adams (age: 78) Dr. Adams holds a Ph.D. in Biochemistry from the University of California, Riverside. The Board believes that Dr. Adams executive leadership and the extensive healthcare expertise he has developed makes Dr. Adams ideally qualified to serve as an additional director of the Company.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Emotional Wellness Company DSOL Announces New CEO as Founder Steps Up To Chairwoman
Drug Free Solution Inc.February 4, 2021 GMT
Chicago, IL, Feb. 04, 2021 (GLOBE NEWSWIRE) via NewMediaWire Drug Free Solution, Inc. dba Get Your Feelz On (OTC: DSOL): The Board of Directors announced today that Genie O’Malley, Founder/CEO, has stepped up to the position of Chairwoman of the Board of Directors, and Jessica Bass, business management finance alum University of Illinois, has officially accepted the position of CEO at Drug Free Solution, Inc. effective immediately.
Beating cancer: MEPs react to the EU Plan for joint action eureporter.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eureporter.co Daily Mail and Mail on Sunday newspapers.